(Q37063465)

18 August 2017

1 reference

title

Warfarin reversal in anticoagulant-associated intracerebral hemorrhage (English)

1 reference

18 August 2017

1 reference

1 reference

1 reference

2

Jonathan Rosand

1 reference

18 August 2017

3

Lee H Schwamm

1 reference

18 August 2017

Joshua N Goldstein

1

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

9

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

277-283

1 reference

Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

Emergency reversal of anticoagulation after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-008-9049-Z

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

12 December 2020

Managing oral anticoagulant therapy

1 reference

12 December 2020

Guidelines on oral anticoagulation: third edition

1 reference

12 December 2020

Spontaneous intracerebral haemorrhage: an analysis of factors affecting prognosis.

1 reference

12 December 2020

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

1 reference

12 December 2020

Ultra-early hemostatic therapy for acute intracerebral hemorrhage

1 reference

12 December 2020

Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.

1 reference

12 December 2020

Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients

1 reference

12 December 2020

Use of factor IX complex in warfarin-related intracranial hemorrhage

1 reference

12 December 2020

A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin

1 reference

12 December 2020

Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis

1 reference

12 December 2020

The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings

1 reference

12 December 2020

Risks of fresh frozen plasma and platelets

1 reference

12 December 2020

Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects

1 reference

12 December 2020

Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage

1 reference

12 December 2020

Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study

1 reference

12 December 2020

Management of acquired coagulation disorders in emergency and intensive-care medicine

1 reference

12 December 2020

Mechanisms of brain injury after intracerebral haemorrhage.

1 reference

12 December 2020

Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrat

1 reference

12 December 2020

Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.

1 reference

12 December 2020

The increasing incidence of anticoagulant-associated intracerebral hemorrhage

1 reference

12 December 2020

Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis

1 reference

12 December 2020

Why do physicians request fresh frozen plasma?

1 reference

12 December 2020

Hematoma enlargement in spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation

1 reference

12 December 2020

Treatment of trauma patients with intracranial hemorrhage on preinjury warfarin.

1 reference

12 December 2020

Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage

1 reference

12 December 2020

Guidelines on oral anticoagulation (warfarin): third edition--2005 update

1 reference

12 December 2020

Nurse driven protocol for head injured patients on warfarin

1 reference

12 December 2020

Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione

1 reference

12 December 2020

Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma.

1 reference

12 December 2020

Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients.

1 reference

12 December 2020

Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies

1 reference

12 December 2020

Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality

1 reference

12 December 2020

1 reference

12 December 2020

Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital

1 reference

12 December 2020

Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?

1 reference

12 December 2020

Vitamin K for the treatment of asymptomatic coagulopathy associated with oral anticoagulant therapy

1 reference

12 December 2020

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

1 reference

12 December 2020

Urgent reversal of warfarin with prothrombin complex concentrate.

1 reference

12 December 2020

Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care a

1 reference

12 December 2020

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

1 reference

12 December 2020

Spontaneous intracerebral hemorrhage due to coagulation disorders

1 reference

12 December 2020

Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms.

1 reference

12 December 2020

Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy

1 reference

12 December 2020

Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.

1 reference

12 December 2020

Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Anaphylaxis after low dose intravenous vitamin K.

1 reference

12 December 2020

Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.

1 reference

12 December 2020

Death and disability from warfarin-associated intracranial and extracranial hemorrhages

1 reference

12 December 2020

Treatment and prevention of primary intracerebral hemorrhage

1 reference

12 December 2020

Location and outcome of anticoagulant-associated intracerebral hemorrhage

1 reference

12 December 2020

Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage

1 reference

12 December 2020

Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat.

1 reference

12 December 2020

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

1 reference

12 December 2020

Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication

1 reference

12 December 2020

Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics

1 reference

12 December 2020

Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation

1 reference

12 December 2020

The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage

1 reference

12 December 2020

Spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin.

1 reference

12 December 2020

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study

1 reference

12 December 2020

Laboratory Monitoring of High-Dose Factor VIIa Therapy

1 reference

12 December 2020

Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage

1 reference

12 December 2020

Thrombogenicity associated with factor IX complex concentrates

1 reference

12 December 2020

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation

1 reference

12 December 2020

Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study

1 reference

12 December 2020

Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation

1 reference

12 December 2020

Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.

1 reference

12 December 2020

Recombinant activated factor VII for acute intracerebral hemorrhage.

1 reference

12 December 2020

The use of vitamin K in patients on anticoagulant therapy: a practical guide

1 reference

12 December 2020

Anaphylactoid reactions to vitamin K.

1 reference

12 December 2020

Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.

1 reference

12 December 2020

10.1007/S12028-008-9049-Z

Identifiers

DOI

1 reference

18 August 2017

1 reference